Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HyperVue™ Software

K-Number: K251198 · 2025-07-16

Decision Date2025-07-16
Product CodeNQQ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

HyperVue™ Software is a medical device manufactured by Spectrawave, Inc.. It received FDA 510(k) clearance on 2025-07-16 under approval number K251198. The device is classified under product code NQQ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HyperVue™ Software?

HyperVue™ Software is a medical device that received FDA 510(k) clearance on 2025-07-16. It is manufactured by Spectrawave, Inc.. The 510(k) number is K251198.

When was HyperVue™ Software approved by the FDA?

HyperVue™ Software received FDA 510(k) clearance on 2025-07-16, under approval number K251198.

What company makes HyperVue™ Software?

HyperVue™ Software is manufactured by Spectrawave, Inc..

What is the FDA product code for HyperVue™ Software?

The FDA product code for HyperVue™ Software is NQQ.

Other Devices by Spectrawave, Inc.

Related Devices (Code: NQQ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.